Literature DB >> 2361377

Acute preload effects of furosemide.

P A Kraus1, J Lipman, P J Becker.   

Abstract

Acute preload effects (as reflected by the pulmonary capillary wedge pressure [PCWP]) of an intravenous furosemide bolus were studied in 33 patients. In those patients receiving no vasoactive drug and in those receiving predominantly preload reducing agents, there was an initial rise in PCWP up until 15 minutes followed by a diuresis-induced fall in PCWP below baseline levels at 1 h. Patients who were receiving preload and significant afterload reduction showed an immediate drop in PCWP which was sustained. This trend is independent of underlying pathology or dose of furosemide used. It is postulated that furosemide causes an early deleterious release of endogenous vasoconstrictors which may be blocked by combined preload and afterload reduction.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2361377     DOI: 10.1378/chest.98.1.124

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  4 in total

1.  Acute decompensated heart failure.

Authors:  Joe Nemeth
Journal:  CMAJ       Date:  2007-07-17       Impact factor: 8.262

Review 2.  Current perspectives on the dysregulated microRNAs in gastric cancer.

Authors:  Shirin Azarbarzin; Reza Safaralizadeh; Mahdi Banan Khojasteh; Amir Baghbanzadeh; Behzad Baradaran
Journal:  Mol Biol Rep       Date:  2020-08-09       Impact factor: 2.316

Review 3.  Haemodynamic monitoring. Problems, pitfalls and practical solutions.

Authors:  L L Bossaert; H E Demey; R De Jongh; L Heytens
Journal:  Drugs       Date:  1991-06       Impact factor: 9.546

4.  Vasodilators for acute heart failure-A protocol for a systematic review of randomized clinical trials with meta-analysis and Trial Sequential Analysis.

Authors:  Johannes Grand; Olav W Nielsen; Jacob Eifer Møller; Christian Hassager; Janus Christian Jakobsen
Journal:  Acta Anaesthesiol Scand       Date:  2022-08-23       Impact factor: 2.274

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.